Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

HPV Detection Using Self-Collected Menstrual Blood

NCT: NCT07733557 · NOT_YET_RECRUITING

NCT IDNCT07733557
StatusNOT_YET_RECRUITING
Start Date2026-07
Completion2029-07
SponsorSamantha Batman (OTHER)
First posted
Last updated

Brief Summary

This study is evaluating whether human papillomavirus (HPV) can be accurately detected from self-collected menstrual blood samples. Participants who have had routine clinical HPV testing within the previous 90 days will collect a menstrual blood sample at home using a study-provided collection kit. The HPV test result from the menstrual blood sample will be compared with the participant's prior clinical HPV test result to assess agreement between the two methods. The goal is to determine whether menstrual blood collection may provide a feasible, noninvasive approach for HPV testing.

Frequently Asked Questions

What is HPV Detection Using Self-Collected Menstrual Blood?

HPV Detection Using Self-Collected Menstrual Blood is a clinical trial registered under NCT07733557. Current status: NOT_YET_RECRUITING.

What is the status of NCT07733557?

The current status of NCT07733557 (HPV Detection Using Self-Collected Menstrual Blood) is: NOT_YET_RECRUITING.

When did HPV Detection Using Self-Collected Menstrual Blood start?

HPV Detection Using Self-Collected Menstrual Blood started on 2026-07.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.